海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
- Glabellar Frown Lines
- United States
- 2016-02-04
Not recruiting
- Homecoming Line: Telephone Support for Veterans
- Stress Disorders, Post-Traumatic
- United States
- 2016-01-12
Not Recruiting
- A study investigating the efficacy and safety of anetumab ravtansine as 2nd line treatment for malignant pleural mesothelioma.
- Patients with advanced or metastatic malignant pleural mesothelioma overexpressing mesothelin MedDRA version: 20.0 Level: LLT Classification code 10035605 Term: Pleural mesothelioma malignant advanced System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, Finland, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Turkey, United Kingdom, United States
- 2015-10-06
Authorised
- Pembrolizumab as First Line Treatment in Subjects with Recurrent/Metastatic HNSCC.
- Recurrent/metastatic head and neck squamous cell carcinoma. MedDRA version: 20.0 Level: PT Classification code 10071540 Term: Head and neck cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2014-12-22
Not Recruiting
- Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
- Psoriasis MedDRA version: 20.0 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Belgium, Canada, Germany, Hungary, Italy, United States
- 2014-10-28
Recruiting
- Testing Tele-Savvy, an On-line Psychoeducation Program for Dementia Family Caregivers
- Alzheimer Disease;Dementia
- United States
- 2017-01-25
Not recruiting
- Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
- Metastatic Breast Cancer
- United States
- 2005-08-24
Not recruiting
- Recombinant Human Insulin-Like Growth Factor (rhIGF-1) Treatment of Short Stature Associated With IGF-1 Deficiency
- Insulin-Like Growth Factor-1 Deficiency;Growth Disorders;Insulin-Like Growth Factor-1 Deficiency;Growth Disorders;Insulin-Like Growth Factor-1 Deficiency;Growth Disorders;Insulin-Like Growth Factor-1 Deficiency;Growth Disorders
- France, United States
- 2005-07-27
Not recruiting
- Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL
- Non-Hodgkin's Lymphoma
- United States
- 2006-08-24
Not recruiting
- Frequency of Accessing Central Lines for Blood Samples
- Congenital Disorders
- United States
- 2006-08-17
Not recruiting
- Gemox as First and Second Line Therapy in Unknown Primary Cancer
- Unknown Primary Neoplasms
- United States
- 2006-07-13
Not recruiting
- Estrogen Receptor Gene Mutations
- Mutations;Hormones;Mutations;Hormones;Mutations;Hormones;Mutations;Hormones
- United States
- 2006-06-19
Not recruiting
- Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant
- Malaria
- United States
- 2006-05-01
Not recruiting
- Angiotensin II Antagonism of TGF-Beta 1
- Diabetic Nephropathy;Hypertension
- United States
- 2006-04-28
Not recruiting
- Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
- Androgen Independent Prostate Cancer (AIPC);Non Small Cell Lung Cancer (NSCLC)
- Canada, United States
- 2006-01-31
Not recruiting
- Safety and Efficacy of IncobotulinumtoxinA (Xeomin) in the Treatment of Glabellar Frown Lines
- Glabellar Lines
- Canada, Germany, United States
- 2007-08-06
Not recruiting
- Effect of HSV-2 Suppressive Therapy on Sexual Behavior
- Genital Herpes
- United States
- 2007-06-29
Not recruiting
- AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib
- Advanced Renal Cell Carcinoma
- Austria, Belgium, France, Poland, United States
- 2007-04-26
Not recruiting
- POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
- Coccidioidomycosis;Coccidioidomycosis;Coccidioidomycosis;Coccidioidomycosis
- United States
- 2007-01-17
Not recruiting
- A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis
- Chronic Plaque Psoriasis
- Canada, United States
- 2007-01-05